ATE421693T1 - Proteine in der diabetes-proteomanalyse - Google Patents

Proteine in der diabetes-proteomanalyse

Info

Publication number
ATE421693T1
ATE421693T1 AT02742845T AT02742845T ATE421693T1 AT E421693 T1 ATE421693 T1 AT E421693T1 AT 02742845 T AT02742845 T AT 02742845T AT 02742845 T AT02742845 T AT 02742845T AT E421693 T1 ATE421693 T1 AT E421693T1
Authority
AT
Austria
Prior art keywords
diabetes
proteom
proteins
analysis
human
Prior art date
Application number
AT02742845T
Other languages
English (en)
Inventor
Peter Larsen
Stephen Fey
Joern Nerup
Allan Karlsen
Karin Nielsen
Original Assignee
Pride Proteomics As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pride Proteomics As filed Critical Pride Proteomics As
Application granted granted Critical
Publication of ATE421693T1 publication Critical patent/ATE421693T1/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/46—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
    • G01N2333/47—Assays involving proteins of known structure or function as defined in the subgroups
    • G01N2333/4701—Details
    • G01N2333/4703—Regulators; Modulating activity
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/04—Endocrine or metabolic disorders
    • G01N2800/042—Disorders of carbohydrate metabolism, e.g. diabetes, glucose metabolism

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Analytical Chemistry (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Pathology (AREA)
  • Urology & Nephrology (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • Hematology (AREA)
  • Genetics & Genomics (AREA)
  • Microbiology (AREA)
  • General Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Cell Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
AT02742845T 2001-05-29 2002-05-29 Proteine in der diabetes-proteomanalyse ATE421693T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DKPA200100852 2001-05-29

Publications (1)

Publication Number Publication Date
ATE421693T1 true ATE421693T1 (de) 2009-02-15

Family

ID=8160539

Family Applications (1)

Application Number Title Priority Date Filing Date
AT02742845T ATE421693T1 (de) 2001-05-29 2002-05-29 Proteine in der diabetes-proteomanalyse

Country Status (4)

Country Link
EP (2) EP2161578A1 (de)
AT (1) ATE421693T1 (de)
DE (1) DE60230988D1 (de)
WO (1) WO2002097434A1 (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003078456A2 (en) * 2002-03-20 2003-09-25 Syddansk Universitet Human diabetes-mediating proteins
JP2006528361A (ja) * 2004-07-06 2006-12-14 クンイル ファーマシューティカル カンパニー リミテッド アルドラーゼを含む網膜血管疾患診断用組成物およびその診断方法
JP2007063225A (ja) 2005-09-01 2007-03-15 Takeda Chem Ind Ltd イミダゾピリジン化合物
JP5302012B2 (ja) 2006-03-08 2013-10-02 タケダ カリフォルニア インコーポレイテッド グルコキナーゼ活性剤
WO2007143434A2 (en) 2006-05-31 2007-12-13 Takeda San Diego, Inc. Indazole and isoindole derivatives as glucokinase activating agents
EP2091947A2 (de) 2006-12-20 2009-08-26 Takeda San Diego, Inc. Glucokinaseaktivatoren
WO2008116107A2 (en) 2007-03-21 2008-09-25 Takeda San Diego, Inc. Piperazine derivatives as glucokinase activators

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2269646A1 (en) * 1996-10-25 1998-05-14 Peter Mose Larsen Diabetes-mediating proteins and therapeutic uses thereof
US6753314B1 (en) * 1999-04-01 2004-06-22 Curagen Corporation Protein-protein complexes and methods of using same
ATE399793T1 (de) * 1999-04-02 2008-07-15 Corixa Corp Verbindungen und verfahren für therapie und diagnose von lungenkrebs
CA2375850A1 (en) * 1999-06-01 2000-12-07 Proteome Sciences Plc Method and compositions relating to insulin resistance disorders
GB9914890D0 (en) * 1999-06-25 1999-08-25 Univ Buckingham Methods and compositions relating to pancreatic islet and -cell dysfunction

Also Published As

Publication number Publication date
DE60230988D1 (de) 2009-03-12
EP1402257A1 (de) 2004-03-31
WO2002097434A1 (en) 2002-12-05
EP2161578A1 (de) 2010-03-10
EP1402257B1 (de) 2009-01-21

Similar Documents

Publication Publication Date Title
DK221090A (da) Fremgangsmaade og apparat til diagnostisk analyse ved stroemmaaling
ATE283485T1 (de) Verfahren zur diagnose und zur charakterisierung von schlaganfall
DE60028040D1 (de) Annexin-proteine und auto-antikörper als serummarker für lungenkrebs und ösophaguskrebs
DK0943097T3 (da) Fremgangsmåde til at påvise IgE
TWI256975B (en) Compositions containing a urea derivative dye for detecting an analyte and methods for using the same
ATE520026T1 (de) Sequenzielle analyse biologischer proben
DE69733560D1 (de) TESTVERFAHREN UND REAGENZIEN ZUR QUANTIFIZIERUNG VON hBNP
CY1107490T1 (el) Μεθοδος για την ταυτοποιηση δειγματος σε θηλαστικα καθως και κιτ για την εκτελεση αυτης της μεθοδου
DK104093D0 (da) Fremgangsmaade til bestemmelse af collagen-fragmenter i legemsvaesker, test-kit og midler til udoevelse af fremgangsmaaden og anvendelse af fremgangsmaaden til diagnosticering af lidelser associeret til collagen-metabolismen
ATE496294T1 (de) Analyseset mit stechhilfe und messgerät
SE8802944L (sv) Material foer lapptestning
ATE421693T1 (de) Proteine in der diabetes-proteomanalyse
WO2005119209A3 (en) System and method for analyzing microbial growth
AU2003296424A1 (en) Neurotoxic amino acid or neurotoxic derivative thereof associated with neurological disorders
AU2003296085A1 (en) Marker proteins for diagnosing liver disease and method of diagnosing liver disease using the same
DE59911255D1 (de) ELISPOT-Verfahren zur Quantifizierung der Aktivität von menschlichen und tierischen Zellen, zur insbesondere Blutzellen
EP1560025A3 (de) Marker spezifisch für Diabetes
WO2002066982A8 (de) Analyse von modifizierungen und demodifizierungen von proteinen mit ubiquintin-verwandten proteinen mittels fret (fluorescence resonance energy transfer)
CA2358504A1 (en) Methods of determining an increased risk of a woman carrying a downs syndrome affected fetus by measuring an analyte in a biological sample
DE59710505D1 (de) Verwendung von tiefgefrorenem Blut für biologische Untersuchungsverfahren
ATE208040T1 (de) Immunoassay-reagenzien, testsätze und verfahren
DK0878715T3 (da) Cyanidholdig hæmoglobinreagenssammensætning og fremgangsmåder, som giver acceptabel præcision, nøjagtighed og frihed for interferens fra hvide blodlegemer på automatiserede hæmatologi-analysatorer
DK1393078T3 (da) Fremgangsmåder til diagnosticering in vitro eller til overvågning af en sygdom involverende en inflammatorisk reaktion
BR0317224A (pt) Processo de detecção de prp (proteìna priÈnio nativa) com uso de um antibiótico dos aminoglicosìdeos
ATE447045T1 (de) Assoziation von proteinpolymorphismen mit koronarer herzkrankheit

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties